Programming - International Stroke Conference

ISC 2025 Schedule-at-a-Glance

Tuesday, February 4

A separate ticket/registration is required to attend these events

Tuesday, Feb. 4, 2025 Activities
Time Activity
8:00 a.m. to 5:00 p.m. Stroke Nursing Symposium
8:00 a.m. to 5:00 p.m. Fast and Furious: Stroke in the Real World – Addressing Challenges in Acute Stroke Management
8:00 a.m. to 5:30 p.m. HEADS-UP: Health Equity and Actionable Disparities in Stroke: Understanding and Problem-Solving
9:00 a.m. to 5:00 p.m. Stroke in the Lab World: Investigational Targets in Ischemic Stroke: Ready, Set, Translate!

Pre-Con Symposia Programming | Nursing Symposium Programming

Wednesday, February 5
Wednesday, Feb. 5, 2025 Activities
Time Activity
7:30 a.m. to 9:00 a.m.
  • Advances and Controversies in Pediatric Moyamoya Disease
  • Cerebrovascular Inflammatory Disorders the Stroke Neurologist Needs to Know: Blood Vessels on Fire
  • Developing Sustainable and Unique Models for Community Stroke Education
  • Post-stroke Cognitive Impairment and Dementia: New Insights, Challenges and Opportunities
  • Stroke Prevention in the United States and Europe (a European Stroke Organisation / ASA Joint Symposium)
  • Acute Treatment: Systemic Thrombolysis and Cerebroprotection Oral Abstracts I
  • Neuroendovascular Oral Abstracts I
  • Risk Factors and Prevention Oral Abstracts I
9:15 a.m. to 10:45 a.m.
  • Optimal Blood Pressure Management in Acute Cerebrovascular Disease
  • Bench to Bedside and Beyond - Adjunctive Neurostimulation Interventions and Therapies To Maximize Post-Stroke Rehabilitation and Recovery
  • Pathogenesis and Treatment of Non-acute Subdural Hematomas (AANS/CNS CV Section Session)
  • Stroke, Brain Health, and the Brain Economy (an American Academy of Neurology / ASA Joint Symposium)
  • The Paola De Rango Session: Understudied Factors Contributing to Disparities in Stroke Risk and Outcomes in Women Across the Continuum of Disease and Care
  • Clinical Rehabilitation and Recovery Oral Abstracts
  • Imaging Oral Abstracts I
  • Large Vessel Disease from Arteries to Veins (Non-Acute Treatment) Oral Abstracts
11:00 a.m. to 12:30 p.m.

Opening Main Event

  • AHA's Chief Executive Officer’s Welcome and the AHA Presidential Address
  • ISC Program Chair’s Welcoming Remarks
  • Feinberg Award Lecture
  • Late-Breaking Science Trial Results
12:30 p.m. to 2:00 p.m.
  • Moderated Digital Poster Sessions
  • Science and Technology Hall
2:00 p.m. to 3:00 p.m.
  • Cerebrovascular Diseases in Patients with Mechanical Circulatory Support Devices
  • Modernizing Stroke Trials for the 21st Century -Scale, Strategy, and Technology
  • Navigating the Pediatric Ischemic Stroke Landscape: Innovations in Prehospital and Intrahospital Management
  • Cerebrovascular Systems of Care Oral Abstracts I
  • Intracerebral Hemorrhage Oral Abstracts I
  • Late-Breaking Science Oral Abstracts I
  • Risk Factors and Prevention Oral Abstracts II
3:00 p.m. to 3:30 p.m.
  • Moderated Digital Poster Sessions
  • Science and Technology Hall
3:30 p.m. to 4:30 p.m.
  • Bench to Bedside and Beyond -Understanding Sporadic CSVD Through the Lens of CADASIL And Other Monogenic CSVDS
  • Endovascular thrombectomy for distal medium vessel occlusions – How far is too far?
  • Management Decisions Surrounding Antithrombotic Treatment in Patients with ICH: A Physician’s Perspective
  • Reclaiming Sight: Exploring Effective Approaches to Visual Field Recovery after Stroke
  • The Taboo Topic: Sexuality After Stroke
  • Acute Treatment: Systemic Thrombolysis and Cerebroprotection Oral Abstracts II
  • Health Services, Quality Improvement, and Patient-Centered Outcomes Oral Abstracts I
4:45 p.m. to 5:45 p.m.
  • Bench to Bedside and Beyond -Understanding Sporadic CSVD Through the Lens of CADASIL And Other Monogenic CSVDS (cont)
  • Advancements in Stroke services - INDIA: Quality care, Best Practices & New Approaches (an Indian Stroke Association / ASA Joint Symposium)
  • Case Recordings in Live Conditions: Best Management Practices 1
  • It’s All in The Head: Psychological Health is Brain Health
  • Subarachnoid Hemorrhage: Monitoring and Management Complications
  • Health Services, Quality Improvement, and Patient-Centered Outcomes Oral Abstracts II
  • Imaging Oral Abstracts II
  • Neuroendovascular Oral Abstracts II
6:00 p.m. to 7:30 p.m.
  • Moderated Poster Tours
  • Poster Sessions
Thursday, February 6
Thursday, Feb. 6, 2025 Activities
Time Activity
7:30 a.m. to 9:00 a.m.
  • Adding Insult to Injury: Stroke in the Context of Pre-existing Disability and Dementia
  • Advancing Regional Thrombectomy Systems of Care: Global Perspectives
  • Bench to Bedside and Beyond - What Do We Know About the Role of Inflammation in Intracranial Hemorrhage?
  • East Asia Specific Forms of Stroke: RNF213 Related Vasculopathy (a Japan Stroke Society / ASA Joint Symposium)
  • Ramping Up Advanced Practice Provider Scholarship
  • Aneurysms and Vascular Malformations Oral Abstracts
  • Intracerebral Hemorrhage Oral Abstracts II
  • Translational Basic Science Oral Abstracts I
9:15 a.m. to 10:45 a.m.
  • Optimal Imaging for Patient Triage in the Late Time Window and with Large Cores? (Debate)
  • "Where I Am Now" - Evidence-based psychological interventions to improve outcomes of stroke rehabilitation
  • Complexities and Complications: Lessons In Training: Trainee Case Studies Session 1
  • Exploring the Future of ICAD Diagnosis and Management (a JAHA Journal Session)
  • Brain Health Oral Abstracts
  • Late-Breaking Science Oral Abstracts II
  • Risk Factors and Prevention Oral Abstracts III
  • Translational Basic Science Oral Abstracts II
11:00 a.m. to 12:30 p.m.

Thursday Main Event

  • Sacco Outstanding Stroke Research Mentor Lecture
  • Willis Award Lecture
  • Late-Breaking Science Trial Results
12:30 p.m. to 2:00 p.m.
  • Moderated Digital Poster Sessions
  • Science and Technology Hall
2:00 p.m. to 3:00 p.m.
  • Advancing the Understanding of Dolichoectasia: Current Status and Future Directions
  • Aspiration Risk Screening: Updated Evidence and a Call for Advocacy
  • Best Interventions vs. Conservative Management for Unruptured Brain Aneurysms: Assessing the Risks and Benefits
  • Hot Topics on Hot Carotids
  • Stroke in Indigenous and First Nations Populations (an Australian and New Zealand Stroke Organisation / ASA Joint Symposium)
  • AHA Statements and Guidelines: Stroke Primary Prevention
  • Late-Breaking Science Oral Abstracts III
  • Late-Breaking Science Oral Abstracts IV
3:00 p.m. to 3:30 p.m.
  • Moderated Digital Poster Sessions
  • Science and Technology Hall
3:30 p.m. to 4:30 p.m.
  • Case Recordings in Live Conditions: Best Management Practices 2
  • Clinical Translation of Randomized Trials: Challenges, Opportunities, and the Importance Of Designing Trials With Patient And Community Engagement for Implementability
  • In-Hospital Care; from the ICU to Discharge Oral Abstracts
  • Late-Breaking Science Oral Abstracts V
  • 75 Years of NINDS-supported Research to Advance Stroke Prevention, Treatment, and Recovery: From Bench to Bedside and Beyond
  • Bench to Bedside and Beyond - Attacking the Swell: Vascular Permeability and Cerebral Edema Post-Stroke
  • AHA Statements and Guidelines: Updates
4:45 p.m. to 5:45 p.m.
  • Inside the AHA’s Research Enterprise: Grant Funding and Other Opportunities
  • New Horizons in medical therapy for stroke prevention
  • Partnering with Patients to Improve Post-Stroke Care
  • Treatment of Spontaneous Severe Deep Intracerebral Hemorrhage
  • 75 Years of NINDS-supported Research to Advance Stroke Prevention, Treatment, and Recovery: From Bench to Bedside and Beyond (cont)
  • Bench to Bedside and Beyond - Attacking the Swell: Vascular Permeability and Cerebral Edema Post-Stroke (cont)
  • Late-Breaking Science Oral Abstracts VI
  • Game of Strokes
6:00 p.m. to 7:30 p.m.
  • Moderated Digital Poster Sessions
  • Science and Technology Hall
Friday, February 7
Friday, Feb. 7, 2025 Activities
Time Activity
7:30 a.m. to 9:00 a.m.
  • Complexities and Complications: Lessons In Training: Trainee Case Studies Session 2
  • High Profile Thrombolysis Randomized Controlled Trials
  • Innate Immune Targets after Stroke
  • Leveraging Real-World Evidence to Enhance Stroke Outcomes
  • Cerebrovascular Nursing and Advanced Practice Providers and Therapists Oral Abstracts
  • Pediatric Cerebrovascular Disease Oral Abstracts
  • Risk Factors and Prevention Oral Abstracts IV
  • Bugher Foundation Session
9:15 a.m. to 10:45 a.m.
  • Acute Stenting during Endovascular Therapy for Large vessel Occlusions
  • Establishing Stroke Centers of Excellence - Beyond Stroke services and Quality (a World Stroke Organisation / ASA Joint Symposium)
  • New and Alternative Thrombolytic Therapies (a Stroke Journal session)
  • Unspoken Bias: The Influence of Language and Culture on Stroke Care and Research
  • Updates on Cerebral White Matter Disease in 2025: Mechanisms, Implications, Treatment
  • Cerebrovascular Systems of Care Oral Abstracts II
  • Health Services, Quality Improvement, and Patient-Centered Outcomes Oral Abstracts III
  • Translational Basic Science Oral Abstracts III
11:00 a.m. to 1:05 p.m.

Closing Main Event

  • Sherman Award Lecture
  • Late-Breaking Science Trial Results
  • ISC Program Chair's Closing Remarks